Pace Locator develops software that generates 3D maps of cardiac signal origin from ECG and ECHO data to enable noninvasive, real-time visualization of a patient's risk of developing pacing-induced heart failure. The technology leverages a decade of research at the Bern University of Applied Sciences and will launch as a future spin-off. The company plans to first offer heart failure risk assessments via a direct-to-patient model and aims to establish clinical trial partners for a planned international clinical study in 2025. Pace Locator received a CHF 150,000 investment from Venture Kick and will use the funds to accelerate its clinical study and direct-to-patient outreach. The founders are Emily Thompson, a biomedical engineer with expertise in MedTech quality assurance and regulatory affairs, and Bruno Stucki, an electrical engineer experienced in agile hardware and software development. The company cites a target obtainable market of more than CHF 350 million based on more than 3 million people living with pacemakers worldwide and over 600,000 new pacemaker implants annually. Pace Locator estimates that broader use of its solution could represent annual savings of CHF 7 billion for healthcare reimbursement groups that pay for treatment of pacing-induced heart failure.

Total raised

$0M

Funding rounds

1

Latest round

Equity

Latest activity

Feb 2024